The company will manufacture the drug at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.
"Carbamazepine is an anticonvulsant agent. It works by reducing excessive nerve signals in the brain and restoring the normal balance of nerve activity. This medication is used to treat certain types of seizures (partial, generalized tonic-clonic, mixed) and certain types of nerve pain (trigeminal and glossopharyngeal neuralgia)," the company added.
Cadila Healthcare Ltd's share price is currently at Rs323.50, up by Rs1.65 or 0.51%, from its previous close of Rs321.85 on the BSE.